<DOC>
	<DOCNO>NCT03040427</DOCNO>
	<brief_summary>The investigator postulate F-18 florbetapir show improved detection cardiac amyloidosis conventional non-invasive imaging technique , particularly early disease .</brief_summary>
	<brief_title>The Role F-18 Florbetapir Early Detection Cardiac Amyloidosis</brief_title>
	<detailed_description>F-18 florbetapir currently use early detection brain amyloid ( Alzheimer 's disease ) . The hypothesis F-18 florbetapir detect amyloid deposition myocardium prior current non-invasive diagnostic measure , particular electrocardiography strain technetium pyrophosphate scintigraphy . The investigator intend use F-18 florbetapir ass correlation standard non-invasive diagnostic modality .</detailed_description>
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>1 . Patients extracardiac biopsy proven TTR amyloidosis ( i.e . carpal tunnel ) undergone TcPYP scintigraphy within past 90 day . 2 . Patients light chain MGUS light chain ratio &gt; 5 free light chain difference &gt; 50 abnormal NTproBNP &gt; 125 detectable troponin T. 1 . Contraindication tracer component . 2 . Refusal participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>F-18 florbetapir</keyword>
	<keyword>Amyvid</keyword>
	<keyword>PET scan</keyword>
	<keyword>Early detection</keyword>
</DOC>